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We report on the interaction of pulmonary surfactant composed of phospholipids and proteins 
with nanometric alumina (Al2O3) in the context of lung exposure and nanotoxicity. We study 
the bulk properties of phospholipid/nanoparticle dispersions and determine the nature of their 
interactions. The clinical surfactant Curosurf®, both native and extruded, and a protein-free 
surfactant are investigated. The phase behavior of mixed surfactant/particle dispersions was 
determined by optical and electron microscopy, light scattering and zeta potential 
measurements. It exhibits broad similarities with that of strongly interacting nanosystems 
such as polymers, proteins or particles, and supports the hypothesis of electrostatic 
complexation. At a critical stoichiometry, micron sized aggregates arising from the 
association between oppositely charged vesicles and nanoparticles are formed. Contrary to the 
models of lipoprotein corona or of particle wrapping, our work shows that vesicles maintain 
their structural integrity and trap the particles at their surfaces. The agglomeration of particles 
in surfactant phase is a phenomenon of importance since it could change the interactions of 
the particles with lung cells.  
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I - Introduction 
Pulmonary surfactant, the fluid lining the epithelium of the lungs is a complex surface-active 
fluid that contains phospholipids and lipids (85% and 5%, respectively) and 10% proteins 
(SP-A, SP-B, SP-C, SP-D and serum proteins).1-2 The biophysical functions of pulmonary 
surfactant are to prevent the collapse of small alveoli during expiration and the over-
expansion of large alveoli during inspiration. It also preserves bronchiolar patency during 
normal and forced respiration.1,3-4 Furthermore, it has an important immunological role of 
protecting the lungs from injuries and infections caused by inhaled particles, including micro-
organisms, particulate matter or engineered particles.5-10 More specifically, particles of sizes 
less than 100 nm end up significantly deposited in the alveoli, and are susceptible to interact 
with the lung fluid.11-12 
To evaluate the risks of exposure to inhaled nanomaterials, recent studies have been focusing 
on the interaction of particles with membranes, more specifically on model systems made of 
DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) or DOPC (1,2-dioleoyl-sn-glycero-3-
phosphocholine) unilamellar vesicles.13-20 The review of the different interaction potentials 
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between particles and membranes revealed the importance of the interplay between 
particle/vesicle attraction and bilayer bending energy.17 For diameters lower than a critical 
size (order of 10 nm for silica), the particles decorate the outer surface of the membrane, and 
induce aggregation.17-18 For larger particle diameters, supported phospholipid bilayers form 
and coat the particles.13,16 In the latter case, it is suggested that the membrane invaginates and 
eventually engulfs the particle in a process that resembles endocytosis.14,21 In some reports, 
this engulfment is dubbed ingestion or transmigration, because it involves the passage of the 
particle from the outer to the inner part of the object. Ingestion of latex particle (2 µm) was 
first evidenced by Dietrich et al. using time-lapse microscopy and single object 
manipulation.13 Transmigration of silica-based nanoparticles (110 nm) into micron-sized 
liposomes combined with membrane invagination was evidenced by Le Bihan et al. using 
cryo-electron tomography.16 Recent simulations studies have shown that the wrapping of bio-
membranes around particles are favored if the adhesive interactions are sufficiently strong to 
compensate bending.22-25 Simulations were also performed on hydrophobic nanoparticles and 
predicted the formation of a lipoprotein corona or insertion into the membrane.22,24 In 
contrast, very little is known on the interactions between particles and membranes forming 
multi-lamellar vesicles and/or comprising different types of phospholipids and proteins. In 
this context, factors such as vesicle dispersity, variability of the molecular constituents, !" or 
salt concentration of the solvent have to be taken into account, and may lead to specific 
behaviors.  
 
In this work, we use a clinical pulmonary surfactant, Curosurf® (Chiesi Pharmaceuticals, 
Parma, Italy) to evaluate the interactions of particles with membranes relevant to biology. 
Curosurf® is a commercially available surfactant developed as a medication for exogenous 
treatment of respiratory distress syndrome for premature infants. Pulmonary surfactant 
substitutes are either synthetic or derived from animals, and their clinical effects have been 
thoroughly documented.23 As compared to other preparations, Curosurf® contains the highest 
amount of phospholipids and proteins, with concentrations of 76 g L-1 of phospholipids and 
0.45 (resp. 0.59) g L-1 of SP-B (resp. SP-C) membrane proteins and has been shown to be an 
effective surfactant in the treatment of respiratory deficiency. It was shown that Curosurf® 
bulk solutions are dispersions of spherical multilamellar vesicles (MLVs) mainly composed of 
a mixture of phospholipids and surface-active proteins.6,26 Bulk samples were examined using 
freeze-fracture and (cryo)-transmission electron microscopy to determine the size and shape 
distribution of MLVs, and the organization of bilayers in the presence of biological or 
synthetic additives.27-29 
 
Previous studies focused on interfacial and rheological properties of surface layers, as it is 
relevant to its biophysical function in the lungs.19,30-35 In the alveoli however, the pulmonary 
surfactant forms a layer of a few hundreds of nanometers,1,36 and after crossing the air-liquid 
interface the nanoparticles will also interact with the phospholipid sub-phase. This secondary 
process could interfere with phospholipid bulk dynamics and exchanges, and perturb the 
surfactant equilibrium. Some studies of nanoparticles interacting with pulmonary surfactant 
bulk phases were reported, but their number is limited. These studies involved the formation 
of complexes formed at the air/liquid interface, and further analysis on the interactions of 
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these complexes with lung epithelial cells.26,37-41 Issues related to cytotoxicity, lung 
inflammation and ability to cause oxidative stress were also addressed. However, these 
studies do not focus primarily on the main driving forces of interaction. 
 
Here we report on the bulk properties of a synthetic and of purified pulmonary surfactant, and 
highlight the nature of interactions of nanoparticles with phospholipid membranes. In a first 
part, the physico-chemical properties of pulmonary surfactant and particles are thoroughly 
characterized. Emphasis is put on stability, surface charge and ageing behavior of dispersions. 
We also use extrusion to prepare multi-lamellar vesicles of well-characterized size and 
dispersity. As a model of nanoparticle-pulmonary surfactant system, alumina (Al2O3) was 
chosen as it is one of the most widely used material in nanotechnology-based products and its 
toxicological relevance, especially for lungs, is already well-recognized and studied.42-46 The 
formation of complexes between Al2O3-nanoparticles with pulmonary surfactant substitutes is 
demonstrated here. The complexes are the result of electrostatic interactions between 
oppositely charged vesicles and particles.  
 
 
II - Materials and Methods 
II.1 – Materials 
Curosurf® (Chiesi Pharmaceuticals, Parma, Italy) is natural surfactant extract obtained from 
porcine lungs, and containing polar lipids such as phosphatidylcholine (about 70% of total 
phospholipid content), phosphatidylglycerol (about 30% of total phospholipid content) and 
about 1% of hydrophobic proteins SP–B and SP–C. It is suspended in 0.9% sodium chloride 
solution and appears as a white to creamy suspension. According to the manufacturer, its pH 
is adjusted as required with sodium bicarbonate to a pH of 6.2 in average, the actual pH being 
indeed comprised between 5.5 and 6.5 according to the different batches received.31 
Curosurf® was kindly provided by Mostafa Mokhtari (Kremlin-Bicêtre Hospital, Val-de-
Marne, France) and by Ignacio Garcia-Verdugo (INSERM, Paris, France). 
Dipalmitoylphosphatidylcholine (DPPC) was obtained from Sigma-Aldrich, while 2-Oleoyl-
1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) (POPG) and L-α-Phosphatidyl-DL-
glycerol sodium salt from egg yolk lecithin (PG, Sigma-Aldrich, MDL number: 
MFCD00213550) were given by Ignacio Garcia-Verdugo from Institut Pasteur, Paris. 
Aluminum oxide nanoparticles (Disperal®, SASOL) were kindly given by Florent Carn 
(Laboratoire Matière et Sytèmes Complexes, Paris). The powder was dissolved in nitric acid 
(0.4 wt. %) and sonicated for 30 minutes to give suspensions at 10 g L-1. Methanol, nitric acid 
(70%) and poly(diallyldimethylammonium chloride) (PDADMAC, !! < 100 000 g mol-1) 
were purchased from Sigma-Aldrich. Water was deionized with a Millipore Milli-Q Water 
system. All the products were used without further purification. 
 
II.2 – Protein-free surfactant 
Phospholipids DPPC, PG and POPG were initially dissolved in methanol, at 10, 10 and 20 g 
L-1 respectively. These compounds were mixed in proper amounts for a final weight 
concentration of 80%/10%/10% of DPPC/PG/POPG. The solvent was evaporated under low 
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pressure at 60 ˚C for 30 minutes. The lipid film formed on the bottom of the flask was then 
rehydrated with the addition of Milli-Q water at 60 ˚C and agitated at atmospheric pressure 
for another 30 minutes. Milli-Q water was added again to finally obtain a solution at 1 g L-1. 
 
II.3 – Extrusion 
Extrusion of Curosurf® and protein-free surfactant was performed using an Avanti Mini 
Extruder (Avanti Polar Lipids, Inc. Alabama, USA). Solutions were prepared at 1 g L-1 and 
extruded 50 times through Whatman Nucleopor polycarbonate membranes of different pore 
sizes (50, 100, 200 and 800 nm in diameter). For the interaction studies with nano-alumina, 
the MLV dispersions were then diluted to 0.1 g L-1 and the !" was adjusted to !"5 using 0.1 
M hydrochloric acid.  
 
II.4 – Dynamic Light Scattering (DLS) 
Hydrodynamic diameters were measured using a Zetasizer Nano ZS equipment (Malvern 
Instruments, Worcestershore, UK). A 4 mW He-Ne laser beam (! = 633 nm) is used to 
illuminate sample dispersion and the scattered intensity is collected at an angle of 173 
degrees. The second-order autocorrelation function is analyzed using the CONTIN algorithm 
to determine the average diffusion coefficient !! of the scatterers. Hydrodynamic diameter is 
then calculated according to the Stokes-Einstein relation, !! = !!! 3!"!!, where !! is the 
Boltzmann constant, ! the temperature and ! the solvent viscosity. Measurements were 
performed in triplicate at 25° C or 37° C after an equilibration time of 120 s. 
 
II.5 – Zeta potential 
Laser Doppler velocimetry was used to carry out the electrokinetic measurements of 
electrophoretic mobility and zeta potential with the Zetasizer Nano ZS equipment (Malvern 
Instruments, Worcestershore, UK). Measurements were performed 3 times, at 25 °C, after 120 
s of thermal equilibration. 
 
II.6 – Optical microscopy 
Phase-contrast and bright field images were acquired on an IX71 inverted microscope 
(Olympus) equipped with 20×, 40× and 60× objectives. 30 µl of dispersion were deposited on 
a glass plate and sealed into a Gene Frame® (Abgene/Advanced Biotech) dual adhesive 
system. An EXi Blue camera (QImaging) and Metaview software (Universal Imaging Inc.) 
were used as the acquisition system. Silica glass slides were coated using 
poly(diallyldimethylammonium chloride) to improve the surface adhesion of the MLVs. 
 
II.7 – Transmission electron microscopy 
TEM imaging was performed with a Tecnai 12 operating at 80 kV equipped with a 1K×1K 
Keen View camera. For negative staining drops of suspensions were deposited on formvar-
carbon coated 400 mesh copper grids. Negative stains were made with 1% uranyl acetate in 
water.  
 
II.8 – Interaction  
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The interactions between lung fluid models and nanoparticles were investigated using a 
mixing protocol developed by us and had already been tested on a series of strongly 
interacting colloidal systems.47-49 It was checked that this procedure provides reproducible 
results, in particular that the mixing order or concentration does not modify interactions. 
Batches of pulmonary phospholipid phases and nanoparticles were prepared in the same 
conditions of !" (!"!5) and concentration (! = 0.1 g L-1) and then mixed at different ratios, 
noted by ! = !!"#$%&'%(' !!" where !!"#$%&'%(' and !!" denote the volumes of the 
phospholipid and particle solutions respectively. Because the concentrations of the stock 
solutions are identical, the volumetric ratio ! is equivalent to the mass ratio between 
constituents. This procedure was preferred to titration experiments because it allowed 
exploring a broad range in mixing conditions (!! = !10!!!– !10!), while keeping the total 
concentration in the dilute regime and using a low amount of pulmonary fluid and 
particle.48,50-51 The interactions between the phospholipid vesicles and Al2O3 nanoparticles 
occurred rapidly, i.e. within a few seconds after mixing.  
 
 
III - Results and Discussion 
III.1 – Characterization and processability of Curosurf® 
III.1.1 – Structure of native Curosurf 
Curosurf® solutions were prepared from the native dispersions at 76 g L-1 by dilution using 5 
mM phosphate buffer (!" 6.4). Solutions at c = 0.1 and 1 g L-1 were studied using optical 
microscopy and light scattering for characterization at room and body temperatures. 
Microscopy observations reveal the presence of micron sized objects with spherical symmetry 
undergoing rapid Brownian motion. Fig. 1a-d shows a selection of some of the Brownian 
particles, with sizes 0.4 µm, 0.8 µm, 1.6 µm and 3.2 µm respectively. An analysis of 100 
objects resulted in a size distribution of median diameter 1.0 µm and standard deviation 0.5 
µm (Fig. 1e). Referring to earlier studies, these particles are identified as uni- or multilamellar 
vesicles.26-28,32 In this study, large membrane layers or tubular myelin commonly observed in 
the lung fluid were not observed by microscopy.52 Dynamic light scattering performed on the 
same sample shows a bimodal distribution with two major peaks, at 80 and 800 nm (Fig. 1f). 
The DLS peak at 800 nm is in agreement with that found by microscopy. Light scattering also 
shows a population of small vesicles that could not be detected by microscopy. Data on the 
surfactant microstructure obtained at ! = 25 °C or ! = 37 °C, i.e. at temperatures where the 
membranes are in the gel or in the fluid phase respectively, were similar (see differential 
scanning calorimetry data in Supplementary Information, S1).  
 
III.1.2 - Extrusion 
As discussed previously, Curosurf® dispersion in its native state is made of highly disperse 
MLVs. Concerning interactions with particles, dispersity is a major issue, in particular for 
data analysis and interpretation. To overcome this difficulty, extrusion was applied using 
polycarbonate membranes with different pore diameters of 50, 100 and 200 nm. For 
extrusion, native Curosurf® was first diluted to 0.1 g L-1 at !" 6.4, as in the previous section. 
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Figure 1: a-d) Representative images of Curosurf® at the concentration of 0.1 g L-1 obtained 
by phase contrast optical microscopy at T = 25° C (the bar is 3 µm). The sizes for the vesicles 
are indicated in the right hand side of the panel. e) Size distribution deduced from optical 
microscopy. f) Distribution of hydrodynamic diameters of Curosurf® vesicles as determined 
by dynamic light scattering (DLS). 
 
 
 
 
Figure 2: a) Hydrodynamic diameter measured by light scattering as a function of the 
number of passages. Polycarbonate membranes of pore size 50, 100 and 200 nm were used 
and experiments were performed in triplicate. The error bars represent the standard 
deviation. For large extrusion numbers, the bars are smaller than the symbols. The solid lines 
are guides for the eyes. b) Schematic representation of the two-step extrusion process.  
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Fig. 2a shows hydrodynamic diameter of vesicles as a function of the number of passages 
through the membrane. For the first extrusion passages (1 to 5), a sharp decrease in size was 
observed. With further extrusion, a plateau at hydrodynamic diameters 100, 150 and 180 nm 
is reached for membranes of increasing pore sizes. In parallel, the MLV size distribution was 
found to decrease progressively, reaching the final dispersity index of 0.1 ± 0.05 (S2). 
Additional extrusion using an 800 nm-pore membrane was performed for microscopic 
visualization purposes (see Section III.2). 
Based on earlier studies of unilamellar vesicles,53-54 a model was developed that can also 
describe the extrusion of pulmonary surfactant analogues. This model assumes that in the first 
passages, native micron size vesicles are pushed through the pores causing strong 
deformation, membrane tearing and resizing of the structure. At this stage, the exiting vesicles 
are still large and non-uniform. As extrusion progresses, the size mismatch between pores and 
vesicles lessens, giving rise to a Rayleigh-like instability. In the pores, the vesicles are sheared 
and stretched significantly, leading to their breaking into smaller objects (Fig. 2b). Because of 
this stretching, exit diameters are larger than the pore sizes. From purely geometrical 
considerations, the final diameters can be estimated and were found in agreement with 
experimental data (S2). Extrusion turns out to be an easy and reproducible procedure to 
prepare Curosurf® vesicles of predictable size. 
 
 
Figure 3: Hydrodynamic diameter (a) and zeta potential (b) as a function of !" for extruded 
and non-extruded Curosurf® at 0.1 g L-1. Error bars represent the standard deviation of 
experiments performed in triplicate. For extruded Curosurf® (close circles in Fig. 3a) the 
errors bars are smaller than the symbols. The solid lines are guides for the eyes. 
 
 
III.1.3 – Curosurf® stability: effect of !" and ageing 
From a practical standpoint and in anticipation of the work with particles, it is essential to 
know the behavior and stability of the surfactant vesicles as a function of physico-chemical 
parameters, such as concentration, temperature and pH. Hydrodynamic diameter and zeta 
potential of native and extruded Curosurf® were measured over a wide range of !" above 
and below the physiological value (!" 6.4 for newborns). Data are displayed in Figs. 3a and 
3b respectively. With increasing !", the broadly distributed vesicles of native Curosurf® 
decrease by 50% in size (from 800 to 400 nm). In contrast, the diameter of vesicles extruded 
! 8!
through a 50 nm-membrane remains constant at 100 nm. Likewise, the zeta potential is found 
to decrease from positive values at acidic !" (! = + 25 mV) to highly negative ones at 
alkaline !" (! = - 30 mV and -60 mV for the extruded and native state respectively). At 
physiological conditions, we confirmed that phospholipid membranes are negatively 
charged.55 The behaviors found in Fig. 3 can be understood in terms of acid-base properties of 
the phospholipid molecules. At !" below the pKa of the phospholipids (pKa of 456), the 
phosphate moieties are not ionized and the overall charge of the membrane is given by the 
quaternary ammonium groups located in the zwitterionic heads. The rapid decrease of the !-
potential observed around !" 4 is then attributed to the deprotonation of the phosphate 
groups, and the charging of the membrane.  
 
Ageing properties of Curosurf® preparations were investigated over a 30-day period by light 
scattering and zetametry. Experiments were performed every 12 hours, the samples being 
stored at 4° C between measures. Hydrodynamic diameter and zeta potential are displayed in 
Fig. 4a and 4b for native and extruded Curosurf® as well as for the protein-free surfactant for 
7 days after the preparation. For size, native Curosurf® (either at 0.1 and 1 g L-1) exhibits an 
evolution on the first day, but rapidly reaches a steady state. For these samples, the size 
distribution is broad and minor modifications could change the average hydrodynamic 
diameter. In contrast, the extruded samples remain unchanged over the entire period. The zeta 
potential shows a systematic increase from - 60 mV to - 30 mV for all samples, except for 
native Curosurf® at 1 g L-1. Data at 7 and 30 days are moreover identical, confirming the 
good stability of as prepared MLVs. Concerning the origin of the !-potential variations during 
the first days further work is required to clarify this issue. Additional results were acquired 
using up to four freeze-thaw cycles on the native specimens. No significant changes were 
observed either, suggesting that freezing surfactant preparation does not alter its structural 
properties (S3). 
 
Figure 4: Hydrodynamic diameter (a) and zeta potential (b) as a function of time for three 
types of lung fluid substitutes: protein-free surfactant (diamond), extruded (circles) and native 
(squares) Curosurf® at concentrations 0.1 and 1 g L-1. Experiments were performed in 
triplicate and the error bars represent the standard deviation. Continuous lines are guides for 
the eyes. 
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III.2 – Interactions with aluminum oxide particles 
Prior to experiments with pulmonary surfactant, the alumina particles were also thoroughly 
characterized. Dynamic light scattering, TEM and zeta potential measurements were 
performed at concentrations 0.1 to 1 g L-1 and from !" 3 to !" 12 (Figs. 5a and 5b). In the 
inset, a TEM image shows that Al2O3 particles are anisotropic, their shape is that of irregular 
platelets of average dimensions 40 nm long and 10 nm thick. The particles exhibit moreover a 
broad size distribution (Fig. 5a). Electrophoretic measurements show that the particles are 
positively charged at low pH, with ! = + 40 mV. As !" increases above 6, particle surface 
charge decreases progressively and reaches the isoelectric point around !" 10. Beyond, the 
particles are negatively charged. These results are in agreement with those of Cabane and 
coworkers who reported an isoelectric point of 9.3 for alumina particles.57-58 Above !" 6, 
particles also start to aggregate and their hydrodynamic diameter increases, suggesting that 
the stability observed at low !" is caused by electrostatic repulsion. Experiments involving 
pulmonary surfactant and particles were performed at !" 5,where both dispersions are stable.  
 
 
Figure 5: a) Hydrodynamic diameter and zeta potential of alumina particles (1 g L-1) as a 
function of !". Error bars represent the standard deviation of experiments performed in 
triplicate. b) Alumina particles size distribution obtained from transmission electron 
microscopy image analysis. Inset: TEM picture of Al2O3 particles (bar 50 nm). The solid line 
results from least-square calculations using a log-normal distribution with median diameter 
41 nm and dispersity (defined as the ratio between the standard deviation and the average) of 
0.3. 
 
 
Surfactant/nanoparticle dispersions were obtained by mixing stock solutions at different 
volumetric ratios !. This method was successfully tested in the screening of multi-component 
phase diagrams.48,51 In physiological conditions of lung exposure to nanoparticles, pulmonary 
surfactant is in excess and the ratio ! lies in the range 10! − 10!.59 Because of this large 
excess, the dispersion is close to that of pure Curosurf®, and the interactions of the particles 
with the vesicles are difficult to assess. To remedy this shortcoming, the phase behavior of the 
mixed systems was investigated between ! = 10!! and 10!. In this context, it is assumed that 
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the nature of the interactions does not depend on the !-values. Fig. 6 shows the scattering 
intensity (6a to 6c) and the hydrodynamic diameter !! (6d to 6f) as a function of ! at T = 25 
°C. The surfactant phases studied are a protein-free surfactant (Fig. 6a and 6d), and 
dispersions of extruded (using 50 nm pores in Fig. 6b and 6e) and native Curosurf® (Fig. 6c 
and 6f). The solutions were prepared at fixed concentration (0.1 g L-1) for every !. In Figs. 6, 
nanoparticles and surfactant stock solutions are set at ! = 10!! and ! = 10! for 
convenience. For dilute solutions as the ones investigated here, the scattering intensity is 
proportional to the concentration and to the molecular weight of the scatterers. The 
continuous black lines in Figs. 6a, 6b and 6c are calculated assuming that surfactant and 
particles do not interact with each other, and that the scattering is the sum of the intensities 
weighted by their actual concentrations. In Figs. 6a-c, the scattering intensity is found to be 
systematically higher than the predictions for non-interacting species, implying that mixed 
aggregates are formed upon mixing. The scattering maxima ascertain moreover that the 
aggregates have a preferential stoichiometry, as the maximum is peaked at a definite !.  
 
 
Figure 6: Scattered intensity (a, b and c) and hydrodynamic diameter (d, e and f) of alumina 
particles mixtures with protein-free surfactant (a, d), extruded Curosurf® (b, e) and native 
Curosurf® (c, f) as a function of ! (! = 25 °C). ! denotes the ratio between the surfactant 
and nanoparticles weight concentration. Light scattering experiments were performed in 
triplicate. The error bars represent the mean of the standard deviations. Solid lines in blue, 
red and green are guides for the eyes. Continuous lines in black in a, b and c represent the 
scattered intensity calculated assuming that particles and vesicles do not interact.  
 
 
The hydrodynamic diameters !!(!) shown in Figs. 6c-6e confirms this interpretation. The !!-values at maximum reaches 2 µm for the protein-free surfactant, 200 nm and 1.5 µm for 
the extruded and native Curosurf®, and the position of the maxima corresponds to that of the 
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scattering peaks. Similar results were obtained at T = 37 °C, i.e. at temperature where the 
phospholipids are in the disordered liquid state (S4). Fig. 7 displays the histograms of the 
interaction strength between particles and vesicles at the two temperatures, T = 25 °C and 37 
°C. This strength is calculated from the integral of the scattering intensity (color-shaded areas 
in Fig. 6 and S4) with respect to the predictions for non-interacting species. This approach 
shows that surfactant-particle interactions are the strongest for protein-free surfactant, and the 
weakest for native Curosurf®. These conclusions were confirmed from the size data (! = 25 
°C), which show increases by 1500%, 80% and 50% with respect to the uncomplexed 
vesicles. The shift of the scattering maxima for the different formulations (from ! = 1 to 8 in 
Fig. 6a to 6c) is indicative of a predetermined stoichiometry between species. However, the 
number of vesicles and particles in the formed aggregate are difficult to estimate, since the 
relationship between the phospholipid concentration and the vesicle density is yet unknown.60 
This shift in ! suggests however that at a fixed concentration extruded vesicles are more 
numerous that native ones.  
 
 
Figure 7: Integrals over the mixing ratio ! between the scattering intensities as determined 
experimentally and the intensities calculated from non-interacting particles and vesicles 
(colored areas in Fig. 6 and S4). The integral is indicative of the strength of nanoparticle-
surfactant interactions. The labels !, ! and ! are related to the protein-free surfactant, the 
extruded Curosurf® and the native Curosurf®, respectively.  
 
 
To get further insight in the surfactant-Al2O3 mixed structures, dispersions were prepared at 
the maximum of the scattering peak using extruded Curosurf® with 100 nm or 800 nm pore 
membranes. Figs. 8a shows vesicles adsorbed at a silica surface before and after complexation 
with nano-alumina. In the inset, the uncomplexed 800 nm MLVs are isolated and randomly 
distributed on the substrate, whereas in the main frame they form micron-sized aggregates. 
These results are in agreement with the light scattering data (Fig. 6). Due to the sedimentation 
of the largest clusters, aggregates appear larger than those detected by light scattering. A 
close-up view of an aggregate shown in Fig. 8b exhibits characteristic patterns of vesicles at 
close packing inside the formed structure. Fig. 9a and 9b display aggregates observed by 
TEM, using here 100 nm extruded MLVs. The two examples shown are representative of the 
many structures observed using this technique. The cluster structure is dense and the vesicles 
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have a doughnut shape. During the sample preparation, dehydration causes the collapse of the 
MLVs at the center. The vesicles maintain their shape on the border however due to the 
curvature effect of the phospholipid bilayer (Fig. 9c). Similar structures were observed on 
surfactant substitutes28 and on polymer-liposome complexes.29 Note that on the figure the 
Al2O3 particles are not visible, probably because of their weak contrast as compared to that of 
the stained vesicles. A schematic representation of an aggregate is illustrated in Fig. 9d.  
 
 
Figure 8: a) Dispersions of 800 nm Curosurf® vesicles and alumina particles at ratio ! = 7 
observed by phase contrast microscopy (×60). The bar is 20 µm. The sample was prepared at 
c = 0.1 g L-1 and ! = 25 °C and put between glass slides. The silica surfaces were coated 
using poly(diallyldimethylammonium chloride) to improve surface adhesion. Inset: image of 
uncomplexed vesicle in the same experimental conditions (bar 5 µm). b) Close-up view of an 
aggregate (bar 5 µm).  
 
 
Figure 9: a and b) Transmission electron microscopy image of mixed 100 nm extruded 
Curosurf® vesicles and alumina particles (bar 200 nm). c) Close-up view of a single vesicle 
(bar 50 nm) and cartoon illustrating its doughnut height profile on the grid.29 d) Schematic 
representation of nanoparticle-surfactant aggregates.  
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The results here demonstrate that the interaction of nano-alumina with surfactant gives rise to 
the formation of large aggregates, the size of which depends on the ratio between the two 
species. The phase behavior of the mixed dispersions exhibits similarities with that of strongly 
interacting nanosystems such as polymers, proteins or particles, and supports the hypothesis 
of electrostatic complexation. Electrostatic complexation designates the process by which co-
assembly is driven by the pairing of electric charges located at the surfaces of particles or 
along the backbones of macromolecules.49 It is concluded that, in the present experimental 
context the interactions of nano-alumina and surfactant are mainly driven by electrostatic 
forces. The destabilization or reorganization of the vesicles as a result of strong interaction is 
not observed. Encapsulation of alumina particles by vesicles is also not likely to occur. These 
scenarios would indeed result in a decrease in the light scattering data as a function of X, 
which is not observed experimentally. The interactions between nano-alumina and vesicles 
finally appear to be non-specific and independent of the membrane proteins SP-B and SP-C, 
as similar results were observed for protein-free surfactant and Curosurf®. At this point, it is 
difficult to attribute the differences between the protein-free surfactant and the Curosurf® 
(such as those seen in light scattering) to the presence of the proteins.  
 
 
IV - Conclusion 
The pulmonary surfactant layer located at the air-liquid interface in the alveoli is known to be 
the first line of barrier for particles inhaled through the airways. Previous studies on the 
interaction with particles highlighted the modifications of interface properties. After 
deposition at the air-liquid interface however, the particles may dissolve in the surfactant sub-
phase and modify the phospholipid exchanges and equilibrium. To investigate these 
interactions further, a clinical pulmonary surfactant Curosurf® and a synthetic analogue 
composed of phospholipids are characterized and analyzed for their interaction with 40 nm 
alumina nanoparticles. The size, the microstructure, the stability and the nature of the 
dispersion forces of the surfactant phase are the primary physico-chemical indicators to be 
considered when examining the interactions with nanoparticles. These properties were 
examined thoroughly in the present work. On native Curosurf®, data obtained by light 
scattering and microscopy corroborate those reported in the literature:26,28,59 surfactant 
dispersions are made of multilamellar vesicles broadly distributed in size, typically from 100 
nm to 5 µm. To circumvent the issue of the size dispersity, which can be detrimental in some 
cases (in particular in relation with data analysis and treatment), the Curosurf® dispersions 
were extruded using polycarbonate membranes of pores 50 to 800 nm, resulting in the 
generation of highly uniform vesicles. The first result that emerges from this work is that 
native and extruded Curosurf® behave similarly as a function of pH, temperature, stability 
and interactions with particles. We also demonstrate that for the bulk phase extruded 
surfactant represents an excellent model to study. With alumina particles, the interactions give 
rise to the formation of large aggregates made of the vesicles and particles, which is in 
agreement with the phenomenon of electrostatic complexation. The microstructure of the 
aggregates was disclosed using electron and optical microscopy, and it reveals densely packed 
! 14!
clusters made of tens to hundreds of vesicles glued together by the nano-alumina (Fig. 9d). As 
anticipated, the behaviour of particles in Curosurf® bears some similarities with that of 
particles in biological fluids in general, such as plasma serum, lysosomal and interstitial 
fluids.7,15,41,47,61 In these complex environments, the particles are generally found to be coated 
with proteins or with other biomacromolecules (forming then the protein corona), and later to 
agglomerate into clusters of various sizes.62-63 In this respect, the vesicles of the lung 
surfactant substitutes are playing the same role as that of the serum proteins in other 
environments. The agglomeration of particles in biological fluids is a phenomenon of critical 
importance since it results in the loss of the nanometer character of the probes, in changes of 
hydrodynamic properties and interactions with cells. Finally, as compared to recent simulation 
predictions22-25, our results provide a different view. The formation of large vesicular clusters 
is a process that is different from the phenomena of protein/lipoprotein corona or of formation 
of supported bilayers and should be considered when the biological responses are studied 
concerning the effects of nanoparticles in lungs. Moreover, aggregate formation could result 
in the long-term trapping of particles and prevent their interactions with epithelial cells.  
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